A randomised, double-blind, placebo-controlled study to determine the efficacy of soluble beta-1,3/1,6-glucan in chronic foot ulcers in diabetes

Update Il y a 4 ans
Reference: EUCTR2005-005754-50

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the effect of topically administered soluble beta-1,3/1,6-glucan (SBG) compared with that of placebo in chronic foot ulcers in diabetes.


Inclusion criteria

  • Chronic foot ulcers in diabetes

Links